Mass. Pharmaceutical Company Acquired in $5 Billion Deal - NECN
Massachusetts

Massachusetts

The latest news from around the state

Mass. Pharmaceutical Company Acquired in $5 Billion Deal

Parexel International Corp., of Waltham, Massachusetts, is being acquired by Pamplona Capital Management

    processing...

    NEWSLETTERS

    Mass. Pharmaceutical Company Acquired in $5 Billion Deal
    File/AFP/Getty Images

    Parexel International Corp., of Waltham, Massachusetts, is being acquired by Pamplona Capital Management in a $5 billion deal that will make the pharmaceutical contract researcher a private company.

    The private equity fund manager said Tuesday that it will pay $88.10 for each share, which represents a nearly 28 percent premium to the company's stock price in early May before speculation about the deal first began to rise.

    Shares of Parexel jumped more than 4 percent, to $87.60, before the opening bell.

    Parexel provides clinical research, technology consulting and medical communications to the drug and medical device industries.

    Parexel's board has unanimously approved the deal, but shareholders still have to vote on it. The acquisition is expected to close in the fourth quarter.

    Get the latest from necn anywhere, anytime

    • Download the App

      Available for IOS and Android